These results further suggested high expression of ARHGAP11A elevated mortality risk for ccRCC patients, and the mortality rate was 1.782–2.040 times higher than those with low expression of ARHGAP11A (Figure 1D–G). The gene discussed is ARHGAP11A; the disease is nonpapillary renal cell carcinoma.